A <i>FCGR3A</i> Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.

Int J Med Sci · 2018 · PMC5765734 · PMID 29333082

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep=0.12not close (p > 0.1)

In the ADA-producing group of patients, 23.1% were taking an immunomodulator drug and 76.9% were not, although this tendency did not reach statistical significance (p=0.12).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.